At Lilly, we unite caring with discovery to make life better for people around the world. We are a global healthcare leader headquartered in Indianapolis, Indiana. Our employees around the world work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to our communities through philanthropy and volunteerism. We give our best effort to our work, and we put people first. We’re looking for people who are determined to make life better for people around the world.

Actual compensation will depend on a candidate’s education, experience, skills, and geographic location.  The anticipated wage for this position is

$123,000 - $215,600

COLORADO SPRINGS CO ADC 161813

Job Description

Lilly's ongoing research and commercial efforts in Alzheimer’s disease (AD) present one of the most exciting opportunities in the history of the company. There is currently a significant, growing, and intense unmet need across all key players. AD is the sixth leading cause of death in the US, and of the top 10 causes of death, it is the only disease with an increasing mortality rate and the only one that cannot be prevented or cured.

Lilly’s goal is to make the dementia associated with the disease preventable. We are uniquely positioned to achieve this goal: following 30+ years of investment in AD research and development across both therapeutics and diagnostics, Lilly’s landmark Trailblazer-Alz 2 Phase 3 clinical trial published in 2023, the beta-amyloid plaque clearing therapy, donanemab, demonstrated a significant slowing of decline in a composite measure of cognition and daily function in patients with early symptomatic AD. With these ground-breaking positive data, donanemab, brand name Kisunla, was granted FDA approval in July 2024 paving the way for Lilly to address this significant unmet need by promoting Kisunla along with an arsenal of AD diagnostics that support the timely and accurate identification of patients who may benefit from the therapy.

Advanced diagnostics to confirm Alzheimer’s disease pathology are becoming an increasingly critical component of the diagnostic pathway to identify those patients most likely to benefit from therapies like donanemab. Lilly launched Amyvid, the first PET amyloid imaging agent to identify evidence of amyloid pathology in the brains of living patients, in the United States in 2012. In 2020, Tauvid, the first PET tau imaging agent, was approved by the FDA

The combined AD diagnostic and therapeutic ecosystem (referral dynamics, comprehensive diagnostics, treatments, and care management) must be further developed for patients to be diagnosed and treated efficiently and effectively, to support positive customer and patient experiences. This position will be instrumental in supporting the development of the US AD ecosystem, most significantly as it relates to the utilization of, and experience associated with, our Alzheimer’s diagnostic and therapeutic portfolio.
 

Position Description
A variety of elements need to work effectively and in harmony for patients, information, and product to flow smoothly through the process of detecting, diagnosing, and treating people with Alzheimer’s disease. There are multiple steps, stakeholders, and physical locations involved. These interconnected ecosystems (referral dynamics, advanced diagnostics, treatments, and care management), which vary greatly by geography and health system, must be further developed to support overall patient care, so we can facilitate the desired customer experience. The Alzheimer’s Disease Consultant (ADC) is an HCP account specialist who will be instrumental in segmenting, developing, and supporting local healthcare ecosystems, most significantly as it relates to improving the understanding of AD pathology and utilization of Lilly’s AD portfolio, with focus on Amyvid, Tauvid, and Kisunla.
 

The ADC will educate and support a diverse range of customers and care sites, such as memory care centers/Centers of Excellence and affiliated personnel, Neurologists, Neuro-Psychiatrists, infusion centers, imaging centers, nursing and pharmacy staff, and key office personnel. This individual will also compliantly work across internal functions, including Medical Affairs, Medical Diagnostics, Market Managers, and Field Reimbursement teams, as well as with external partners, such as PETNET. Given this complex environment, the need to influence systems of care and identify referral networks these sales professionals will need significant experience in account-based selling and/or working through ambiguity.
 

Key Deliverables

Successfully promote Kisunla with approved, targeted HCPs to treat early symptomatic Alzheimer’s disease.Engage with customers and key office staff by utilizing value-based selling and strategic account management and by leveraging various channels, including personal (e.g., in-person, virtual interactions) and non-personal (e.g., digital, email, etc.)Support positive infusion and infusion monitoring experiences with Kisunla by ensuring all stakeholders are trained and equipped to infuse safely and effectivelySupport positive imaging experiences with Amyvid and Tauvid by ensuring all stakeholders are trained and equipped to scan, read, interpret, report resultsHelp build a healthy Alzheimer’s disease care ecosystem by identifying and influencing -formal and informal referral networks across different stakeholders and health systems to ensure site readinessSuccessfully leverage disease state education to drive awareness and buy-in on the role Alzheimer’s disease biomarkers play in AD pathologyServe as a peer leader among overlapping field partners to enable a coordinated effort ensuring each customer has a consistent, positive experience
 

Job Responsibilities
Include

Create exceptional customer and patient experiences by building strong partnerships across a myriad of customers in multiple care settingsDevelop a strong understanding of customer/practice dynamics, priorities, stakeholders, and goals for the brand target patientWelcome innovative thinking, differing perspectives, and external informationDemonstrate Lilly values and TEAM LILLY behaviors, positively influencing team cultureCollaborate effectively and compliantly with Lilly internal and field cross-functional partners and across the sales teamDevelop a strong working partnership with PETNET Radiopharmacy Territory Managers to build market-level business plans and to ensure imaging center and dementia specialist needs are met
 

Innovate

Earn a reputation as a subject-matter expert and valued resource both internally and externallyEngage with world-leading key thought leaders and clinical expertsDevelop compliant and innovative ways to influence the local AD ecosystem to ensure patients, information, and product flow smoothly from diagnosis to treatment and follow upAs the external environment evolves, anticipate, embrace, and adapt to changeTest, learn, and iterate new ways of approaching customers and building a sustainable infrastructure to support the Alzheimer’s disease care ecosystem
 

Accelerate and Deliver

Create awareness and discuss the importance of key Alzheimer’s disease biomarkers by providing disease state education to customersPromote Amyvid and Tauvid, as appropriate, to facilitate an effective and timely detection/diagnostic processPromote Kisunla to educate customers on the target patient, efficacy, safety, and overall treatment experienceLeverage Strategic Account Management skills to understand patient, product, and monetary flows when a patient is referred for advanced AD diagnostic testing or an infusionDevelop, execute, and continuously evaluate and adjust account/territory plans with business partners with a strong sense of personal and team accountability to resultsEffectively leverage data to inform prioritized, local decision-making to drive business results Determine needs, expectations, and pain points for HCPs, patients, and care settings in local territorySolve problems and address challenges for HCPs when referring a patient for a PET scan or an infusion.

Basic Qualifications

Bachelor’s degreeAt least three years of experience in a field facing role or three years of relevant experienceValid driver’s license and acceptable driving record is requiredQualified candidates must be legally authorized to be employed in the United States. Lilly does not anticipate providing sponsorship for employment visa status (e.g., H-1B or TN status) for this employment position.

Additional Preferences

Strong performance in prior account-based sales experience (e.g., oncology, hospital/ institution, medical device, buy and bill and/ or medical benefit products)Customer continuity is strongly preferred, as applicableMBA, relevant advanced degree (e.g., Pharmacy, RN, MPH, etc.), or certification (e.g., PET/CT technologist)HCP marketing experience in the biotech/ healthcare industryAlzheimer’s disease, Diagnostics, Neuroscience/Neurology, or related experienceClinical background in Alzheimer’s Disease or the diagnostics spaceLive inside geography or within 30 miles of geography boundariesExperience in a fast paced and dynamic environment with an ability to synthesize the complex and to create and execute effective action plans.Strong business analytics and strategic thinking skills with the ability to navigate ambiguityProven ability to work well cross functionally and collaboratively.Exemplary ability to demonstrate resilience, grit, and appropriately self-resolve problems.Proven track record of successSelf-starter who works with minimal directionInnovative thinkerCuriosity to thrive in white spaceDisplays resilience and tenacity necessary to overcome challengesAbility to comprehend and explain complex clinical studiesAbility to comprehend, utilize, and communicate technical information

Lilly is dedicated to helping individuals with disabilities to actively engage in the workforce, ensuring equal opportunities when vying for positions. If you require accommodation to submit a resume for a position at Lilly, please complete the accommodation request form (https://careers.lilly.com/us/en/workplace-accommodation) for further assistance. Please note this is for individuals to request an accommodation as part of the application process and any other correspondence will not receive a response.

Lilly is an EEO/Affirmative Action Employer and does not discriminate on the basis of age, race, color, religion, gender, sexual orientation, gender identity, gender expression, national origin, protected veteran status, disability or any other legally protected status.

Our employee resource groups (ERGs) offer strong support networks for their members and help our company develop talented individuals for future leadership roles. Our current groups include: Africa, Middle East, Central Asia Network, African American Network, Chinese Culture Network, Early Career Professionals, Japanese International Leadership Network (JILN), Lilly India Network, Organization of Latinos at Lilly, PRIDE (LGBTQ + Allies), Veterans Leadership Network, Women’s Network, Working and Living with Disabilities. Learn more about all of our groups.

Full-time equivalent employees also will be eligible for a company bonus (depending, in part, on company and individual performance). In addition, Lilly offers a comprehensive benefit program to eligible employees, including eligibility to participate in a company-sponsored 401(k); pension; vacation benefits; eligibility for medical, dental, vision and prescription drug benefits; flexible benefits (e.g., healthcare and/or dependent day care flexible spending accounts); life insurance and death benefits; certain time off and leave of absence benefits; and well-being benefits (e.g., employee assistance program, fitness benefits, and employee clubs and activities).Lilly reserves the right to amend, modify, or terminate its compensation and benefit programs in its sole discretion and Lilly’s compensation practices and guidelines will apply regarding the details of any promotion or transfer of Lilly employees.

#WeAreLilly